GLP-1 drugs could become personalized for individuals, study says

descriptions off, selected

captions settings, opens captions settings dialog

captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

End of dialog window.

The Hill's Headlines (PM) - July 30, 2026

The Hill's Headlines (PM) - July 30, 2026

(NewsNation) — A new study conducted by leading researchers across the U.S. suggests GLP-1 drugs could have a much greater impact beyond obesity.

GLP-1s have become known as something of a go-to weight-loss drug. The research, published in “Diabetes, Obesity, and Metabolism,” illustrated that a variance in dosage or type of drug can impact results.

Researchers from the University of Pennsylvania’s Perelman School of Medicine, the Yale School of Medicine, and UT Southwestern Medical Center used information from over 13,000........

© The Hill